It was a pleasure to participate in the BIOTOOL-CHF Project General Assembly and discuss how this exciting project (and clinical study) is progressing. Thank you Elena Toschi for sharing how ECRIN is contributing at this time toward the study approval.
Another impactful day of presentations at the BIOTOOL-CHF General Assembly in Paris! 🌍 🔗 Igor Diemberger from the University of Bologna (Alma Mater Studiorum – Università di Bologna) highlighted the importance of stakeholder engagement and integrating devices to manage congestion. 📝 Salvatore Di Somma, representing AISC - Associazione Italiana Scompensati Cardiaci, introduced a patient questionnaire designed to enhance patient-centered insights in our research. 🔍 Elena Toschi from ECRIN (European Clinical Research Infrastructure Network) presented on the local coordination efforts essential for clinical study approval 🛡️ Agnese Amati from Warrant Hub European Funding Development - Tinexta Group led a session focused on the exploitation and protection strategy, crucial for maximizing project impact and safeguarding innovations. 🌐 Marwa Atef Eid Eid from the University of Bologna (Alma Mater Studiorum – Università di Bologna) presented remotely, discussing the exploitation plan for the companion diagnostic toolkit—an essential component in advancing diagnostics. 📣 Finally, Stefania Melandri from Warrant Hub European Funding Development - Tinexta Group provided an update on the project’s communication and dissemination activities, along with exciting plans for the months ahead. The BIOTOOL-CHF project is making strides in the fight against chronic heart failure. More updates to follow! #BIOTOOL | #EUHorizon | #ChronicHeartFailure | INSERM